{"altmetric_id":1647947,"counts":{"readers":{"mendeley":19,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":2,"unique_users":["736625766","275419205891361"],"posts_count":2},"total":{"posts_count":12},"twitter":{"unique_users_count":5,"unique_users":["POSTECTRIMS","Rene_Robles_C","UNIEMGirona","hurtasun","MSMmeeting"],"posts_count":10}},"selected_quotes":["JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment","M\u00e1s referencia mencionada"],"citation":{"abstract":"Progressive multifocal leukoencephalopathy is the most common clinical presentation of JC virus (JCV)-associated central nervous system (CNS) disease and has emerged as a major safety concern in multiple sclerosis patients treated with the monoclonal antibody natalizumab. Here we report clinical, radiological, and histological findings of a case of cerebellar granule cell neuronopathy (GCN), a JCV-associated CNS disease, so far unreported amongst patients treated with natalizumab. GCN should be considered as a JCV CNS manifestation in patients with newly developed, progressive cerebellar signs under natalizumab treatment, especially in cases where cerebellar atrophy can be visualized by magnetic resonance imaging.","abstract_source":"pubmed","altmetric_jid":"4f6fa5e63cf058f610005726","authors":["Schippling S","Kempf C","B\u00fcchele F","Jelcic I","Bozinov O","Bont A","Linnebank M","Sospedra M","Weller M","Budka H","Martin R","Schippling, Sven","Kempf, Christian","B\u00fcchele, Fabian","Jelcic, Ivan","Bozinov, Oliver","Bont, Adriano","Linnebank, Michael","Sospedra, Mireia","Weller, Michael","Budka, Herbert","Martin, Roland"],"doi":"10.1002\/ana.23973","endpage":"626","first_seen_on":"2013-07-25T03:24:34+00:00","issns":["1531-8249","0364-5134"],"issue":"4","journal":"Annals of Neurology","last_mentioned_on":1493141402,"links":["http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ana.23973\/abstract","https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23868420"],"pdf_url":"http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ana.23973\/pdf","pmid":"23868420","pubdate":"2013-01-01T00:00:00+00:00","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Neurosciences","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Neuroscience"],"startpage":"622","subjects":["neurology"],"title":"JCV granule cell neuronopathy and GCN\u00e2\u0080\u0090IRIS under natalizumab treatment","type":"article","volume":"74","mendeley_url":"http:\/\/www.mendeley.com\/research\/jc-virus-granule-cell-neuronopathy-gcniris-under-natalizumab-treatment"},"altmetric_score":{"score":2.85,"score_history":{"1y":2.35,"6m":0.25,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":2.85},"context_for_score":{"all":{"total_number_of_other_articles":8099079,"mean":6.8881653514065,"rank":3159853,"this_scored_higher_than_pct":60,"this_scored_higher_than":4904339,"rank_type":"exact","sample_size":8099079,"percentile":60},"similar_age_3m":{"total_number_of_other_articles":127664,"mean":7.0382951520803,"rank":38466,"this_scored_higher_than_pct":69,"this_scored_higher_than":88511,"rank_type":"exact","sample_size":127664,"percentile":69},"this_journal":{"total_number_of_other_articles":2380,"mean":11.077315678857,"rank":1501,"this_scored_higher_than_pct":36,"this_scored_higher_than":872,"rank_type":"exact","sample_size":2380,"percentile":36},"similar_age_this_journal_3m":{"total_number_of_other_articles":8,"mean":13.642285714286,"rank":4,"this_scored_higher_than_pct":50,"this_scored_higher_than":4,"rank_type":"exact","sample_size":8,"percentile":50}}},"demographics":{"poster_types":{"member_of_the_public":4,"researcher":1},"users":{"twitter":{"cohorts":{"Members of the public":4,"Scientists":1}},"mendeley":{"by_status":{"Professor > Associate Professor":2,"Researcher":6,"Student  > Ph. D. Student":4,"Student  > Postgraduate":1,"Other":3,"Student  > Master":1,"Student  > Bachelor":1,"Professor":1},"by_discipline":{"Medicine and Dentistry":13,"Social Sciences":1,"Agricultural and Biological Sciences":3,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":1}}},"geo":{"twitter":{"ES":2,"AT":1},"mendeley":{"NL":1,"GB":1,"DE":1}}},"posts":{"facebook":[{"title":"JCV granule cell neuronopathy and GCN-IRIS under ... [Ann Neurol. 2013] - PubMed - NCBI","url":"https:\/\/www.facebook.com\/736625766\/posts\/10151828844970767","license":"public","citation_ids":[1647947],"posted_on":"2013-08-12T18:43:59+00:00","summary":"Freaky scary stuff for anybody who is on the ms drug Tysabri. (For your information, if you are not in the loop, nobody knows what causes ms and most ms drugs concentrate on WEAKENING the immune system so that the immune system stops attacking the body ner","author":{"name":"Brian White","url":"https:\/\/www.facebook.com\/736625766","facebook_wall_name":false,"image":"https:\/\/graph.facebook.com\/736625766\/picture","id_on_source":"736625766"}},{"title":"JCV granule cell neuronopathy and GCN-IRIS under natalizumab treatment - Schippling - Annals of...","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=403844329715514&id=275419205891361","license":"public","citation_ids":[1647947],"posted_on":"2013-07-24T17:30:00+00:00","summary":"\"Annals of Neurology\u201d Brief Communication: JCV granule cell neuronopathy and GCN-IRIS under natalizumab treatment.","author":{"name":"American Neurological Association","url":"https:\/\/www.facebook.com\/275419205891361","facebook_wall_name":"American Neurological Association","image":"https:\/\/graph.facebook.com\/275419205891361\/picture","id_on_source":"275419205891361"}}],"twitter":[{"url":"http:\/\/twitter.com\/POSTECTRIMS\/statuses\/789499112630738944","license":"gnip","citation_ids":[705161,12986755,1647947,12986756],"posted_on":"2016-10-21T16:10:31+00:00","author":{"name":"POSTECTRIMS","url":"http:\/\/9nl.cc\/iiyn","image":"https:\/\/pbs.twimg.com\/profile_images\/724904040946106368\/IydOgBk4_normal.jpg","description":"Canal para sanitarios interesados en #EsclerosisMultiple. Retransmisi\u00f3n X Reuni\u00f3n #postEctrims 10-11 Nov 17 #ectrims Farmacovigilancia: http:\/\/xs.gy\/7evr","id_on_source":"POSTECTRIMS","tweeter_id":"379971177","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1401},"tweet_id":"789499112630738944"},{"url":"http:\/\/twitter.com\/Rene_Robles_C\/statuses\/789499195501735936","license":"gnip","rt":["POSTECTRIMS"],"citation_ids":[705161,12986755,1647947,12986756],"posted_on":"2016-10-21T16:10:51+00:00","author":{"name":"Ren\u00e9 Robles Cede\u00f1o","image":"https:\/\/pbs.twimg.com\/profile_images\/2631452271\/8eec73f275b7653ac1bc2df51a74a87d_normal.png","description":"Neurologist. Associate professor. Computing-gadget lover. Amateur drummer.","id_on_source":"Rene_Robles_C","tweeter_id":"329085723","geo":{"lt":41.98311,"ln":2.82493,"country":"ES"},"followers":341},"tweet_id":"789499195501735936"},{"url":"http:\/\/twitter.com\/UNIEMGirona\/statuses\/789499305610608640","license":"gnip","rt":["POSTECTRIMS"],"citation_ids":[705161,12986755,1647947,12986756],"posted_on":"2016-10-21T16:11:17+00:00","author":{"name":"UNIEMTG","image":"https:\/\/pbs.twimg.com\/profile_images\/1506404908\/Nou_logo_versio__petita_normal.jpg","description":"Unitat de Neuroimmunologia i Esclerosi M\u00faltiple Territorial Girona","id_on_source":"UNIEMGirona","tweeter_id":"329846559","geo":{"lt":null,"ln":null},"followers":79},"tweet_id":"789499305610608640"},{"url":"http:\/\/twitter.com\/hurtasun\/statuses\/789500729920749568","license":"gnip","rt":["POSTECTRIMS"],"citation_ids":[705161,12986755,1647947,12986756],"posted_on":"2016-10-21T16:16:56+00:00","author":{"name":"Hurtasun","image":"https:\/\/pbs.twimg.com\/profile_images\/652530905907613696\/ugbUhWkl_normal.jpg","id_on_source":"hurtasun","tweeter_id":"2403167128","geo":{"lt":null,"ln":null},"followers":10},"tweet_id":"789500729920749568"},{"url":"http:\/\/twitter.com\/MSMmeeting\/statuses\/812591206945406976","license":"gnip","citation_ids":[1647947],"posted_on":"2016-12-24T09:30:15+00:00","author":{"name":"MS Management","url":"https:\/\/www.multiplesclerosismanagement.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/699176937579741184\/GYGxN_-v_normal.png","description":"Channel to HCP interested in #MultipleSclerosis. Broadcast of the MS Management meeting #MSM16, Vienna, March 11th-12th, 2016. Supported by Teva Neuroscience","id_on_source":"MSMmeeting","tweeter_id":"4806099981","geo":{"lt":48.33333,"ln":15.75,"country":"AT"},"followers":405},"tweet_id":"812591206945406976"},{"url":"http:\/\/twitter.com\/MSMmeeting\/statuses\/815143009121693696","license":"gnip","citation_ids":[1647947],"posted_on":"2016-12-31T10:30:12+00:00","author":{"name":"MS Management","url":"https:\/\/www.multiplesclerosismanagement.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/699176937579741184\/GYGxN_-v_normal.png","description":"Channel to HCP interested in #MultipleSclerosis. Broadcast of the MS Management meeting #MSM16, Vienna, March 11th-12th, 2016. Supported by Teva Neuroscience","id_on_source":"MSMmeeting","tweeter_id":"4806099981","geo":{"lt":48.33333,"ln":15.75,"country":"AT"},"followers":405},"tweet_id":"815143009121693696"},{"url":"http:\/\/twitter.com\/POSTECTRIMS\/statuses\/849177225979191296","license":"gnip","citation_ids":[1647947],"posted_on":"2017-04-04T08:30:02+00:00","author":{"name":"POSTECTRIMS","url":"http:\/\/9nl.cc\/iiyn","image":"https:\/\/pbs.twimg.com\/profile_images\/724904040946106368\/IydOgBk4_normal.jpg","description":"Canal para sanitarios interesados en #EsclerosisMultiple. Retransmisi\u00f3n X Reuni\u00f3n #postEctrims 10-11 Nov 17 #ectrims Farmacovigilancia: http:\/\/xs.gy\/7evr","id_on_source":"POSTECTRIMS","tweeter_id":"379971177","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1401},"tweet_id":"849177225979191296"},{"url":"http:\/\/twitter.com\/POSTECTRIMS\/statuses\/851729042210398208","license":"gnip","citation_ids":[1647947],"posted_on":"2017-04-11T09:30:02+00:00","author":{"name":"POSTECTRIMS","url":"http:\/\/9nl.cc\/iiyn","image":"https:\/\/pbs.twimg.com\/profile_images\/724904040946106368\/IydOgBk4_normal.jpg","description":"Canal para sanitarios interesados en #EsclerosisMultiple. Retransmisi\u00f3n X Reuni\u00f3n #postEctrims 10-11 Nov 17 #ectrims Farmacovigilancia: http:\/\/xs.gy\/7evr","id_on_source":"POSTECTRIMS","tweeter_id":"379971177","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1401},"tweet_id":"851729042210398208"},{"url":"http:\/\/twitter.com\/POSTECTRIMS\/statuses\/854284629410549760","license":"gnip","citation_ids":[1647947],"posted_on":"2017-04-18T10:45:02+00:00","author":{"name":"POSTECTRIMS","url":"http:\/\/9nl.cc\/iiyn","image":"https:\/\/pbs.twimg.com\/profile_images\/724904040946106368\/IydOgBk4_normal.jpg","description":"Canal para sanitarios interesados en #EsclerosisMultiple. Retransmisi\u00f3n X Reuni\u00f3n #postEctrims 10-11 Nov 17 #ectrims Farmacovigilancia: http:\/\/xs.gy\/7evr","id_on_source":"POSTECTRIMS","tweeter_id":"379971177","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1401},"tweet_id":"854284629410549760"},{"url":"http:\/\/twitter.com\/POSTECTRIMS\/statuses\/856923268351221761","license":"gnip","citation_ids":[1647947],"posted_on":"2017-04-25T17:30:02+00:00","author":{"name":"POSTECTRIMS","url":"http:\/\/9nl.cc\/iiyn","image":"https:\/\/pbs.twimg.com\/profile_images\/724904040946106368\/IydOgBk4_normal.jpg","description":"Canal para sanitarios interesados en #EsclerosisMultiple. Retransmisi\u00f3n X Reuni\u00f3n #postEctrims 10-11 Nov 17 #ectrims Farmacovigilancia: http:\/\/xs.gy\/7evr","id_on_source":"POSTECTRIMS","tweeter_id":"379971177","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1401},"tweet_id":"856923268351221761"}]}}